mit-tech-review
PublishedJuly 27, 2026 at 11:40 AM
—neutral
Closing the data loop in AI-driven drug discovery

Publisher summary· verbatim
Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law. Today, bringing a new drug
Stay posted· Newsletter
Three short emails a week: Monday, Wednesday and Friday. Top movers, new models and the most-referenced story.
Your email is used only to send The Bubble Brief. Privacy policy
Discussion
No replies yet. Be first.
Related coverage
More from MIT-TECH-REVIEW
mit-tech-reviewIndustrial Intelligence: The next growth opportunity for manufacturing10hThe Bubble Brief
MON · WED · FRIRead AI insights every Monday, Wednesday and Friday — top movers, new models, story of the week.
Your email is used only to send The Bubble Brief. Privacy policy
Originally published on mit-tech-review ↗